FDA Adds Black Box Warning To Label For Conventional Antipsychotics
This article was originally published in The Pink Sheet Daily
Executive Summary
Physicians advised of increased mortality risk when the drugs are used off-label to treat psychosis in elderly dementia patients.
You may also be interested in...
Antipsychotic Not Certain Savior For Forest
Cariprazine shows potential in top-line Phase II, as milnacipran PDUFA date – and firm’s patent cliff – grow near.
Antipsychotic Not Certain Savior For Forest
Cariprazine shows potential in top-line Phase II, as milnacipran PDUFA date – and firm’s patent cliff – grow near.
FDA’s Fluoroquinolone Fight With Public Citizen Will Continue Despite New Warning
FDA is requiring a boxed warning and a medication guide for the antibiotics due to the risk of tendon injuries but is not mandating a letter to doctors as requested in Public Citizen’s lawsuit.